Physicochemical Descriptors

Property Name Value
Molecular Formula C29H45GdN4O16
Molecular Weight 862.94
AlogP None
Hydrogen Bond Acceptor None
Hydrogen Bond Donor None
Number of Rotational Bond None
Polar Surface Area None
Molecular species None
Aromatic Rings None
Heavy Atoms None

Pharmacology

Action Mechanism of Action Reference
None Diagnostic agent

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hernias, Diaphragmatic, Congenital 3 D065630 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
13.04
Nervous system disorders
12.76
Skin and subcutaneous tissue disorders
11.92
Respiratory, thoracic and mediastinal disorders
9.79
Immune system disorders
9.54
Vascular disorders
7.81
Gastrointestinal disorders
7.37
Cardiac disorders
6.82
Psychiatric disorders
5.23
Injury, poisoning and procedural complications
4.5
Musculoskeletal and connective tissue disorders
4.37
Investigations
2.38
Eye disorders
2.05

Cross References

Resources Reference
ChEMBL CHEMBL1200571
FDA SRS 3Q6PPC19PO
PubChem 49799998